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ABSTRACT: The mechanisms behind the Amyloid-β (Aβ)
peptide neurotoxicity in Alzheimer’s disease are intensely
studied and under debate. One suggested mechanism is that
the peptides assemble in biological membranes to form β-
barrel shaped oligomeric pores that induce cell leakage. Direct
detection of such putative assemblies and their exact
oligomeric states is however complicated by a high level of
heterogeneity. The theory consequently remains controversial,
and the actual formation of pore structures is disputed. We
herein overcome the heterogeneity problem by employing a
native mass spectrometry approach and demonstrate that
Aβ(1−42) peptides form coclusters with membrane mimetic detergent micelles. The coclusters are gently ionized using
nanoelectrospray and transferred into the mass spectrometer where the detergent molecules are stripped away using collisional
activation. We show that Aβ(1−42) indeed oligomerizes over time in the micellar environment, forming hexamers with collision
cross sections in agreement with a general β-barrel structure. We also show that such oligomers are maintained and even
stabilized by addition of lipids. Aβ(1−40) on the other hand form signiﬁcantly lower amounts of oligomers, which are also of
lower oligomeric state compared to Aβ(1−42) oligomers. Our results thus support the oligomeric pore hypothesis as one
important cell toxicity mechanism in Alzheimer’s disease. The presented native mass spectrometry approach is a promising way
to study such potentially very neurotoxic species and how they could be stabilized or destabilized by molecules of cellular or
therapeutic relevance.
■ INTRODUCTION
The Amyloid-β (Aβ) peptide is a small (39−43 amino acids)
amphiphilic peptide which is produced by proteolytic cleavage
of an integral membrane protein, the Amyloid Precursor
Protein (APP). The central and C-terminal parts of Aβ belong
to a segment of the transmembrane domain of APP, while the
Aβ N-terminal segment (residues 1−16) is found on the
extracellular part of APP, outside the cell membrane.1 The Aβ
peptide aggregates spontaneously in aqueous solution, forming
amyloid ﬁbrils similar to those found in the brain of
Alzheimer’s disease (AD) patients. Aβ production, aggregation,
and accumulation are therefore important hallmarks of AD
pathology.2 It has however been reported that AD pathology
severity does not correlate well with the concentration of
amyloid plaques. Instead the soluble pool of Aβ seems to be
related to neurodegeneration.3 It has been proposed that the
small oligomeric forms of Aβ are the most neurotoxic species.
One suggested mechanism for such toxicity is that a peptide
oligomer inserts into the cellular membrane as a pore and
induces cell leakage.4,5 The longer Aβ(1−42) is also more
neurotoxic than Aβ(1−40), which is more abundant in the cell.
Signiﬁcant diﬀerences between the two isoforms have
furthermore been observed when it comes to primary
nucleation rates for aggregation, oligomerization states, and
interactions with membranes.6−8
Although the membrane disturbing properties of Aβ are well
established, the exact molecular mechanisms remain elusive.
The idea of pore forming oligomers is a highly controversial
one and is challenged by several other theories. Other
membrane damaging mechanisms which have some exper-
imental evidence include mechanical disruption and/or
extraction of lipids by growing ﬁbril structures, as well as
change of membrane curvature and/or thickness by mem-
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brane−peptide interactions.9−12 It is also highly probable that
several of these mechanisms can occur simultaneously or
sequentially during experimental conditions. A two-step
mechanism for membrane disruption by Aβ has been proposed
where ion selective pores are ﬁrst formed, followed by general
membrane fragmentation damage by growing amyloid ﬁbrils.13
A cellular membrane also has various physicochemical
properties which could aﬀect its interaction with Aβ, and
also modulate the diﬀerent toxicity mechanisms. Surface
curvature and membrane thickness have for instance been
shown to aﬀect amyloid aggregation and toxicity.14,15
Due to the complexity of biological membranes, simpler
membrane-like systems are often used for detailed studies of
Aβ interactions with membranes. Several biochemical and
biophysical techniques, as well as membrane mimetic systems
are available to probe the interactions.16 Detection of putative
Aβ pore-structures is however challenging as the Aβ
population is a heterogeneous mixture of diﬀerent water-
soluble and insoluble aggregates, both in solution and in
membrane mimicking environments.17,18 It should be noted
that Aβ oligomers are generally not well-deﬁned, and despite
careful attempts their heterogeneous sizes and structures are
not yet well characterized. Formation of both β-sheet
structured and disordered oligomers have been demonstra-
ted.19,20 It has also been suggested that β-sheet structured and
unstructured oligomers coexist as Aβ aggregation proceeds via
two distinct pathways, with the β-sheet structured aggregates
being the most neurotoxic.21
Recently a systematic study was published which outlined a
reproducible protocol for preparation of small β-barrel pore-
forming oligomers (βPFO) in membrane mimicking mi-
celles.22 It was found that Aβ(1−42), but not Aβ(1−40),
formed such βPFOs and that zwitterionic dodecylphosphocho-
line (PC12, DPC) micelles yielded the highest amount of β-
sheet structured oligomers (As seen by CD and NMR
spectroscopy). The study showed that micelle-βPFOAβ(1−42)
cocomplexes of approximately 60 kDa were formed (deter-
mined by size exclusion chromatography) under such
conditions. The exact size or size distribution of
βPFOAβ(1−42) without detergent was however not reported.
In the present study, we employ native mass spectrometry to
detect the formation of speciﬁc Aβ oligomers in a membrane
mimicking environment. Native mass spectrometry, i.e. the use
of gentle conditions to retain speciﬁc noncovalent interactions
in the gas phase, has emerged as a powerful tool in structural
biology. Such use of mass spectrometry allows for rapid
identiﬁcation of complex stoichiometry, protein modiﬁcations,
and binding of speciﬁc cofactors.23 Mass spectrometry can also
be coupled to ion mobility (IM) spectrometry which is a
related gas phase technique that separates ions according to
their collisional cross section (CCS, Ω). For proteins, such
observations give information about both their conformations
and about oligomeric states that overlap in the mass
spectrometric m/z dimension. Native IM-MS has shown that
Aβ(1−42) and Aβ(1−40) oligomers in solution diﬀer
signiﬁcantly: Aβ(1−42) adopts an open tetramer structure
leading to formation of higher oligomer states while Aβ(1−40)
oligomerization stops at a closed tetramer.6 However,
oligomerization in a membrane-like environment has never
been previously reported using native (IM-)MS.
The application of native mass spectrometry has been
extended to study membrane proteins using membrane
mimicking systems. Detergent micelles are most commonly
used to stabilize membrane proteins, but lipid based models
such as nanodiscs have also been successfully employed.24−26
The intact protein-model membrane cocluster is ionized under
gentle electrospray conditions, whereafter the protein is
liberated from the membrane mimicking environment by
collision induced dissociation (CID) in the mass spectrometer.
This procedure is used to enable precise mass and ion mobility
measurements of the stripped protein or protein complex.27,28
Here we demonstrate that near-isotropic β-barrel-like
Aβ(1−42) hexamers are indeed formed and enriched upon
incubation in zwitterionic phosphocholine micelles, supporting
the proposed βPFO mediated membrane disruption.22
■ METHODS
Sample Preparation. βPFOsAβ(1−42) were prepared as described
previously.22 Brieﬂy, human recombinant Aβ(1−42) (rPeptide) was
dissolved in 10 mM Tris-HCl (Amresco) pH 9.0 with PC12 as
incubation detergent (Avanti Lipids) in a 1:2 peptide/micelle ratio
(typically 100 μM peptide and 4.5 mM incubation detergent PC12,
corresponding to 3 × CMC) and incubated under quiescent
conditions at 37 °C for 24 h. After incubation, the sample was
puriﬁed for analysis by size exclusion chromatography (SEC) using a
Superdex 75 10/300 GL column (GE Healthcare) and a mobile phase
of 10 mM ammonium acetate (Invitrogen) pH 9 with 1 mM nonionic
Dodecyl Maltoside (DDM) as analysis detergent (Anatrace) (6.7 ×
CMC). The fractions were collected, and the secondary structure of
each fraction was determined using circular dichroism (CD)
spectroscopy. The fractions containing the presumed βPFOsAβ(1−42)-
micelle complexes (larger apparent mass than the monomer and β-
sheet structure) were ﬂash frozen in liquid nitrogen and stored at −80
°C until analysis. The samples were further buﬀer exchanged into 200
mM ammonium acetate pH 7.5 with 0.3 mM of the analysis detergent
DDM (2 × CMC) right before analysis using Micro-BioSpin P6 (Bio-
Rad) columns.
Mass Spectrometry and Ion Mobility. A Waters Synapt G2S
hybrid mass/ion mobility spectrometer equipped with a nano-
electrospray source was used for analysis. Samples were introduced
using commercial metal coated borosilicate spray emitters (Thermo
Scientiﬁc). Ionization was performed in positive ion mode, and the
instrument parameters were as follows: Capillary voltage 1.7 kV,
Sampling cone 40 V, Source oﬀset 80 V, Trap gas 10 mL/min,
Helium Gas Flow 100 mL/min, IM gas ﬂow 50 mL/min, IM wave
velocity 750 m/s, IM wave height 24 V. CID was performed by using
collisional energies between 100 and 200 V in the IM Trap region of
the instrument.
Drift times from IM-MS for βPFOsAβ(1−42) were calibrated to
obtain CCS values as described elsewhere.29 Human insulin (Sigma),
bovine ubiquitin (Sigma), and bovine milk β-lactoglobulin (Sigma)
were used as calibrants. More speciﬁcally, the insulin monomer (+3, +
4), dimer (+5, +6), hexamer (+9, +11), ubiquitin monomer (+4, +5),
β-lactoglobulin monomer (+7, +8, +9), and dimer (+11, +12, +13)
ions were used for calibration, as they span the m/z range of Aβ(1−
42) dimers to hexamers. Reference CCSs for these calibrants were
obtained from published work performed on drift tube ion mobility
instruments.30,31 A calibration curve was obtained (Figure S17) with a
maximum back-calculated CCS error of ±5% for the calibrant
proteins.
Structure Modeling. The Aβ monomer is known to transiently
fold into a β-hairpin structure in aqueous solution, which can be
captured and stabilized in an aﬃbody complex.32 Engineered stable β-
hairpin structured Aβ peptides rapidly form stable β-sheet structured
oligomers that do not proceed to form amyloid ﬁbrils.21,33 A previous
study has also found (using CD and NMR spectroscopy) that the
presumed βPFOsAβ(1−42) formed during the experimental conditions
employed in this study have predominately β-sheet structure.22
The solution state NMR structure of the Aβ monomer in complex
with the ZAβ3 aﬃbody dimer (pdb: 2otk) was therefore selected as a
reasonable building block for the βPFO model.32 All atoms of the
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aﬃbody dimer were removed, and the N-terminal part of another
NMR model of Aβ (pdb: 1ba434) was added (since the N-terminal
part (1−15) of the Aβ peptide is missing from pdb 2otk due to its
ﬂexible nature in solution). The initial pdb stuctures and the ﬁnal
monomer model are shown in Figure S1.
Oligomeric models were constructed from this monomeric unit by
ab initio docking using the homo-oligomer docking server
GalaxyHomomer.35 Further reﬁnement of the docked structure was
done using GalaxyReﬁneComplex, which uses a Monte Carlo
algorithm and Molecular Dynamics simulations for relaxation and
energy minimization of the docked complex.36 The theoretical CCS
values for the models were calculated using the Trajectory Method of
IMPACT.37
■ RESULTS AND DISCUSSION
Ion mobility resolved Aβ(1−42) hexamers can be
detected in the presence of micelles. Upon 24 h
incubation of Aβ(1−42) with PC-12 and separation by SEC
chromatography, a new peak with a higher apparent molecular
weight than the Aβ(1−42) monomer appeared in the SEC
chromatogram. CD spectroscopy conﬁrmed β-sheet structure
in the fraction corresponding to that peak (Figure S2). Direct
analysis of this fraction eluted in 10 mM ammonium acetate
buﬀer with 1 mM analysis detergent. DDM resulted in a mass
spectrum with major peaks from free DDM molecules or small
detergent clusters. Less intense signals corresponding to Aβ
monomers and small oligomers were also detectable after
collisional activation and detergent dissociation (Figure S3).
Signiﬁcantly more intense signals were obtained after perform-
ing buﬀer exchange into 200 mM ammonium acetate with 0.3
mM of the analysis detergent DDM (2 × CMC) resulting in
the spectrum in Figure 1A. A trap collision energy of at least
100 V was required for declustering of detergent and detection
of oligomeric Aβ signals. Increased trap collision energy
resulted in not only better signal-to-noise ratios but also a shift
toward lower m/z values as well as drift time changes (Figure
S4). These drift time shifts only occur at m/z signals
containing overlapping oligomeric forms, indicating oligomer
dissociation rather than unfolding events.
The signals which were coeluting in the “oligomer” SEC
peak were ﬁrst putatively annotated by their oligomer/charge
(n/z) ratio by comparing the measured m/z values to the
theoretical values for oligomers of Aβ(1−42). Theoretical
oligomer m/z values are shown in Figure 1B with the
experimentally observed signals marked in red. Considerable
Figure 1. (A) Mass spectrum of βPFOsAβ(1−42). The sample was collected from the β-sheet structured oligomer SEC fraction and buﬀer exchanged
into 0.3 mM of the analysis detergent DDM (2 × CMC) with 200 mM ammonium acetate before analysis. Inset shows a closer look at the region
where larger oligomers are expected to appear. Peaks can be observed which can be matched to theoretical Aβ(1−42) oligomeric states. The
notation used is the oligomeric state divided by the charge state (n/z). Note for example that 2/3 can therefore contain dimer (+3), tetramer (+6),
and hexamer (+9) components. (B) The oligomer peaks in part A have been assigned by comparing the experimentally found n/z values to the
theoretically calculated n/z values. The experimentally observed states are shown in red font. It can be seen that the largest oligomer where a
continuous series of charge states is observed is the hexamer. Signals conﬁrmed by IM to correspond to a speciﬁc oligomeric state are shown in
bold and underlined. (C) The fraction of each overlapping peak that correspond to a speciﬁc oligomer signal can be extracted by IM. The IM-
selected MS peaks for the diﬀerent oligomers together with a Gaussian ﬁt are shown in color; the total spectrum is shown in black. The red circles
in the black total spectrum indicate the total added intensity of the diﬀerent deconvoluted oligomeric components, indicating that the six
oligomeric components are enough to fully explain the Aβ peaks observed in the mass spectrum.
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overlaps of peak series are expected in the m/z dimension as n-
mers can also carry n times the monomer charge. The n/z ratio
is therefore a very useful notation for the experimentally
observed signals (For example, the n/z = 2/3 signal could
consist of a dimer (2/3), tetramer (4/6), and hexamer (6/9)
component). It can be seen in Figure 1B that the hexamer is
the largest oligomer where a complete series of charge states,
with a Gaussian-like envelope including both even and odd
charge states, was detected. The only putative heptamer signal
is at n/z = 1 (“7/7”) which overlaps with all other oligomers.
As detected charge states in Figure 1B fall on a somewhat
linear trend line (increasing the oligomeric state increases the
solvent exposed surface area, which leads to a proportional
increase in average charge state), one would expect that the
most intense charge state for the heptamer would be 7/8 or 7/
9, neither of which are found experimentally. The potential
octamer signals shown in Figure 1B are only from even charge
states, which overlap heavily with signals for other smaller
oligomers, making these unlikely to originate from the
octamer. This indicates that the hexamer is the largest detected
oligomer. As can be seen in Figure S5 the average charge state
per monomer decreases for each oligomeric state. The
decrease is however smaller between the tetramer and the
pentamer, while the hexamer displays a slight increase in
Figure 2. (A) Mass spectrum of Aβ(1−42) after 90 min of incubation in 5.5 mM DPC at 37 °C and buﬀer exchange to 0.3 mM DDM. The
oligomeric region is shown as an insert. It can be seen that the spectrum is very similar to that from the βPFOAβ(1−42) sample in Figure 1A. The
intensity for the most intense oligomeric peak (2/3) is approximately 2% of the intensity of the monomeric signals. (B) Mass spectrum of Aβ(1−
40) after 90 min of incubation in 5.5 mM DPC at 37 °C and buﬀer exchange to 0.3 mM DDM. Oligomeric signals are fewer and have lower relative
intensity compared to the signals from Aβ(1−42) shown in part A. The intensity for the most intense oligomeric peak (n/z = 2/3) is only
approximately 0.02% of the intensity of the monomer. (C) Drift time proﬁles for the n/z = 2/3 and 3/4 signals which for Aβ(1−42) contain
overlapping oligomeric signals. It can be seen that the component representing the hexameric state signiﬁcantly smaller for Aβ(1−40) compared to
Aβ(1−42) (marked with black arrows).
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average charge. Charging in electrospray can be explained in
terms of protein conformation and accessible surface area, as is
further discussed in the last part of the results section.
By taking advantage of the capability of ion mobility to
deconvolute oligomer series which overlap in the m/z
dimension but diﬀer in drift time, oligomers were separated
and deﬁnitively assigned using the IM dimension. The drift
times for ion mobility species of overlapping n/z, which
depends on charge as well as the size of the particles, were
corrected by multiplication with the ion charge at a given
oligomeric state. Peaks from diﬀerent n/z states with
approximately overlapping charge-corrected drift times were
assigned to be of the same oligomeric state. This corresponds
to drift time peaks of a particular oligomeric state
approximately falling on a diagonal trend line in the driftogram
(Figure S6). Using this simple approach most drift time peaks
could be assigned to an oligomeric state. The assignment
procedure is shown in Figure S7. The drift time assignment of
each oligomeric n/z signal can be found in Figure S8. Higher
charge states often exhibit several drift time peaks even though
the n/z should not contain overlapping oligomeric states (for
example 2/5, 5/7, 4/7, Figure S8). This occurrence of ions
with multiple cross sections could be explained by the presence
of subunit rearrangement or alternative topologies for such
ions of higher charge states.38,39
The contributions of the individual oligomeric states to
overlapping n/z signals were picked out using the IM
dimension as shown in Figure 1C. All IM-ﬁltered oligomer
m/z peaks follow Gaussian shaped charge state distributions,
which points toward correct IM annotation. The red circles in
Figure 1C indicate the sum of intensities for the diﬀerent
deconvoluted oligomer components in a given n/z signal. The
match between the sum of assigned components and the
measured mass spectrum indicate that the monomer and six
oligomer states are suﬃcient to fully explain the experimental
data in the m/z dimension.
Aβ(1−40) form signiﬁcantly lower amounts of
oligomers compared to Aβ(1−42). The results from
Aβ(1−42) were compared to those from Aβ(1−40). No
βPFO peak of higher apparent molecular weight was observed
in the SEC chromatogram for incubated Aβ(1−40), as had
been reported earlier. To study the formation of oligomers we
instead incubated Aβ(1−40) and Aβ(1−42) in the incubation
detergent PC12 for only 90 min. The samples were then buﬀer
exchanged into 200 mM ammonium acetate pH 9 with 0.3
mM DDM using Micro-BioSpin P6 columns and immediately
analyzed in IM-MS. As can be seen in Figure 2A and B, large
diﬀerences between the results from two proteoforms could be
observed: Aβ(1−42) form almost identical oligomer distribu-
tions after 90 min as after 24 h. In contrast, Aβ(1−40)
displayed 2 orders of magnitude lower oligomeric signals
relative to the monomeric signal (with approximately the same
total monomeric signal intensity) as well as fewer overall
oligomer signals and an oligomeric population shifted toward
lower oligomers of mostly dimers and trimers (Figure 2).
Aβ(1−40) does also not exhibit a complete charge state series
for the hexamer, lacking the unique n/z = 6/7 charge state.
The ion mobility of possibly overlapping oligomers such as n/z
= 2/3 and 3/4 also show that the ion mobility peaks annotated
to the hexamer are considerably smaller than for Aβ(1−42)
(Figure 2C). Aβ(1−42) could still be successfully sprayed
without problem after 24 h of incubation while no spectrum
could be obtained from Aβ(1−40) due to immediate clogging
of the electrospray needle, indicating heterogeneous formation
of amyloid ﬁbrils. βPFOsAβ(1−42) are stable for several days in
room temperature while Aβ(1−40) rapidly goes on to form
amyloid ﬁbrils without signiﬁcantly populating the βPFO state
after the ﬁrst hours of incubation.
These results show that while oligomers are enriched in
PC12 micelles for Aβ(1−42), they form at much smaller
amounts for Aβ(1−40) and are of lower average oligomeric
states. A minimum oligomer size is needed to create an internal
cavity where leakage across a biological membrane could be
facilitated. It could therefore be considered that smaller
oligomers should be less toxic than larger oligomers based
on the hypothesis of a pore formation−neurotoxicity
connection. From our docked models of the Aβ(1−42) β-
hairpin monomer, it seems like the tetramer is the smallest β-
hairpin oligomer which is big enough to be able to form a
proper pore structure (Figure S9). Larger oligomers are more
likely to form pore structures and are therefore of increased
interest for the toxicity mechanism of the peptide. This is in
agreement with a structure−toxicity study which shows
correlation between pore formation and toxicity for Aβ
oligomers larger than the tetramer.40
These diﬀerent behaviors in a membrane-mimicking
environment, where Aβ(1−40) mostly form oligomers smaller
than this critical pore formation size, could indicate a
molecular background for the diﬀerences in toxicity between
the Aβ(1−40) and Aβ(1−42).
The micellar environment enriches partially buried
oligomers which assemble over time. More intense
oligomer signals and oligomers of lower average charge are
observed for the βPFOsAβ(1−42) samples compared to Aβ(1−
42) in a detergent-free solution (Figure S10). The charging in
electrospray ionization under native conditions is typically
proportional to the solvent accessible surface area of the
protein.41 The charge of micelle-embedded proteins after CID
removal of detergent consequently corresponds to the charge
that would be carried by a soluble protein of the same size as
the soluble part of the membrane protein.42,43 In this case, the
low amount of charges per monomer is similar to the charging
which has previously been observed for the hydrophilic Aβ(1−
16) segment in solution.44 The sparsely charged species that
we observe therefore indicates that the peptide ions are from a
micelle-bound origin, as the micelle makes some protonation
sites unavailable. The N-terminal parts are most likely located
outside of the micelle due to their hydrophilicity, as has been
observed for the monomer in micelles.45 These hydrophilic
segments are therefore probably the regions in the
βPFOsAβ(1−42) which acquire the charge during the electro-
spray process. Similar shifts toward lower electrospray charge
states have previously been observed for Aβ(1−40) monomers
inserted in zwitterionic micelles, but not in the presence of
nonionic micelles where the peptide is not inserted.46 As a
control experiment a peptide with the same amino acid
composition as Aβ(1−42) but with a scrambled sequence
(Aβ(1−42)Scr.) was used (Sequence in Supporting Informa-
tion). As can be seen in Figure S11A, the hydrophobicity of
Aβ(1−42)Scr is more equally distributed along the peptide
sequence compared to Aβ(1−42). Aβ(1−42)Scr was treated
exactly as Aβ(1−42) and was incubated in PC12 and buﬀer
exchanged into DDM for analysis. Aβ(1−42)Scr monomers
showed the same charge state distribution as Aβ(1−42) in a
detergent-free solution even at high activation energies needed
to remove the detergent. However, no oligomer signals could
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be observed in Aβ(1−42)Scr (Figure S11B−C). Both micelle
insertion and oligomer formation therefore seem to be
sequence speciﬁc for the Aβ(1−42) peptide.
To further examine if the observed Aβ(1−42) oligomers are
of micelle-bound origin, the sample was fractionated using an
Amicon Ultra centrifugal ﬁlter (Merck) with a 30 kDa cutoﬀ.
The βPFOsAβ(1−42) could still be detected in the retentate,
while only monomers and oligomers of lower n/z ratio (1/4,
1/3, and 2/5) could be detected in the ﬁltrate (Figure S12).
This conﬁrms that the observed oligomeric signals from the
βPFOsAβ(1−42) samples are part of larger peptide-micelle
coclusters in solution, as all observed oligomers have molecular
masses below 30 kDa in the absence of detergent.
The βPFOsAβ(1−42) samples do also not form amyloid ﬁbrils
to the same extent as the corresponding micelle-free samples
(Figure S13). Previous studies have shown that the Aβ
oligomer population never reaches more than 1.5% of the total
Aβ monomer concentration during amyloid aggregation
studies under micelle-free in vitro conditions.47 It would not
be appropriate to use mass spectrometry data to determine the
absolute quantitative oligomer concentration. However, the
relative increase in oligomeric Aβ(1−42) signals upon
incubation in micelles indicates an overall increase in the
oligomer population compared to the micelle-free conditions.
The increased oligomer population and decreased ﬁbrillation
rate at these βPFO-forming conditions therefore suggest that
Aβ(1−42) oligomers can potentially be enriched in cellular
membranes. Such enrichment could play an important role in
AD pathology, as oligomers have a higher toxicity compared to
mature amyloid ﬁbrils.48−50
Increased detergent concentration at constant peptide
concentration, i.e. a decrease in the theoretical peptide:micelle
ratio, resulted in changes in the oligomer distribution as could
be seen by IM-MS. Detergent concentrations below the formal
CMC of the incubation detergent PC12 resulted in detection
of predominantly hexamers at the n/z = 2/3 signal. Increasing
the amount of PC12 during incubation resulted in an absolute
signal increase for all oligomeric states at n/z = 2/3 (Figure 3A,
top and middle panels), indicating a detergent driven
oligomerization process. A relative shift toward smaller
oligomers could also be observed, probably due to dilution
of the peptides in the larger pool of detergent. However, if the
diluted peptide−micelle mixture was incubated for a short
period of time, a shift back toward larger oligomers was
observed (Figure 3A, middle and lower panels), demonstrating
that larger peptide oligomers assemble inside the micelles over
time in an equilibrium process. The dissociation of oligomers
upon dilution points toward a somewhat low stability of the
structures. The reassembly however implies that the oligomers
are energetically favorable compared to the state with
dispersed monomers. Favorable monomer−detergent inter-
actions could lead to an energy barrier for oligomerization, and
incubation time is therefore needed to reform the complexes.
The same shift toward lower oligomers at higher detergent
concentration could also be observed by increasing the
concentration of the DDM detergent used during analysis
(Figure 3B).
Addition of PC lipids stabilizes larger oligomers. A
detergent micelle is only a membrane-mimicking environment,
and some caution should be taken when interpreting the
results in terms of more biological contexts. The phosphocho-
line headgroup of the incubation detergent PC12 is a
biologically relevant chemical motif, making this particular
detergent reasonably relevant in a cellular context. In order to
evaluate the stabilities of the βPFOsAβ(1−42) in a lipid
environment, the samples were titrated with a proper PC
lipid (See Supporting Information), 1-palmitoyl-2-oleoyl-
glycero-3-phosphocholine (POPC, 16:0−18:1 PC). Mixed
micelles and bicelles are formed when lipids are added to
detergent micelles, which are characterized by their [lipid]/
[detergent] ratio (q-value). The βPFOsAβ(1−42) were titrated
with lipid to a q-value of 0.4. The oligomeric ensembles were
left entirely intact as seen by their MS signals. No additional
oligomeric signals were detected, but a small shift in relative
intensity of the signal ensemble toward oligomers with larger
n/z values could be observed (Figure S14). Ion mobility
further conﬁrms that the βPFOsAβ(1−42) are shifted toward
larger oligomeric states at overlapping n/z signals (Figure 4),
indicating a stabilizing eﬀect of PC lipids on the complexes.
The major part of the βPFOs are detected in the unbound
delipidated state, but PC binding can be observed. Ion mobility
conﬁrms the oligomeric identity of such binding events, which
also further conﬁrms the proposed IM annotation (Figure
S15). It can also be seen in Figure S15 that lipid binding does
not seem to alter the βPFO in a way that signiﬁcantly changes
the drift time of the 2/3 hexameric ion.
Other lipid classes might have diﬀerent eﬀects on
stabilization or destabilization of the βPFOsAβ(1−42) and
could possibly also display a stronger speciﬁc binding aﬃnity
to the complexes. The herein described methodology could in
the future be used to screen for such diﬀerent properties.
Oligomers adopt near-isotropic β-barrel-like struc-
tures. Collisional cross section (CCS) values were determined
for the experimental βPFOAβ(1−42)IM signals. The type of
oligomer assembly can be determined by studying the CCS
Figure 3. (A) Ion mobility drift times for Aβ(1−42) n/z = 2/3
dimers/tetramers/hexamers etc. ions with diﬀerent concentrations of
PC12 detergent. The relative oligomer distribution shift toward
smaller species as the detergent concentration is increased (top,
middle). The amount of larger oligomers is however increasing again
upon incubation (middle, bottom). The relative intensities are
indicated, with the most intense peak as “100%”. (B) The same
behavior for the n/z = 2/3 ion is observed when varying the amount
of DDM detergent during analysis.
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growth upon increasing oligomeric size.51 Linear growth (Ωn =
Ω1·n) indicates a strong spatial “1D” dependence typical of
ﬁbril assembly into roughly cylindrical structures, while
isotropic growth (Ωn = Ω1·n2/3) indicates assembly into
granular “3D” aggregates. It has been found that some
amyloidogenic peptides oligomerize in an isotropic manner
while others grow linearly.51 The experimentally found and the
theoretically calculated CCS values assuming idealized linear
and idealized isotropic growth can be seen in Figure 3A. The
growth of the Aβ(1−42) oligomers clearly agrees well with
isotropic growth, indicating the formation of near-spherical or
“3D” structures rather than extended linear or “1D” sheet
structures.
This isotropic growth is also reﬂected in the average charge
of the oligomeric states as seen in Figure S5. Average charge
state and charge state distributions depend on the solvent
accessible surface area of the protein as discussed previously,
which is correlated to the CCS. It can even be argued that
charge state distribution analysis gives better information on
the solution state structure of proteins as electrospray charging
occurs in solution while CCS values are measured on gas phase
structures.52 Information from charge states is particularly
useful for unstructured proteins and protein segments.53 Both
the average charge state (Figure S5) and CCS (Figure 5)
suggest that the hexamer is slightly more extended and/or
solvent exposed than the simple isotropic model would
suggest. This could be an indication of a structure which
form a somewhat hollow pore structure, while the smaller
oligomers are not large enough to do this.
The hexamer is the largest observed oligomer under these
conditions. It probably also has a size that easily permits
formation of hollow structures (Figure S9). Several theoretical
hexamer models were constructed to compare with the
experimental ﬁndings. Ab initio docking of the hairpin
structured Aβ monomer (Figure S1) resulted in a symmetrical
β-barrel structure as the best scored hexamer model from the
docking. The theoretical CCS of this hexamer model was
calculated to 2610 Å2. An experimental CCS of 2100 ± 300 Å2
(95% conﬁdence interval) was measured for the hexamer if
averaged over all charge states, this is somewhat smaller than
the value for the theoretical model. This could be attributed to
the fact that the unstructured N-terminal parts are very
extended in the model structure. If the N-terminal parts are
removed entirely, a model CCS of 1740 Å2 is obtained, which
Figure 4. (A) Ion mobility drift times for Aβ(1−42) n/z = 1 and n/z
= 2/3 at diﬀerent [lipid]/[detergent] ratios (q-value) upon titration
with 16:0−18:1 PC lipid to βPFOsAβ(1−42) in DDM (0.36 mM). The
relative oligomer distributions at a given n/z value shift toward larger
oligomers (lower drift times) at higher q-values.
Figure 5. (A) Experimentally found CCS values for the βPFOsAβ(1−42). The determined CCS values for each charge state are given in the open
circles while the red squares represent the average CCS over all charge states for a given oligomeric state. The calculated (equations shown in
ﬁgure) theoretical CCS values for ideal linear and isotropic growth of the measured monomer CCS are plotted in solid and dashed lines,
respectively. It can be seen that the data for Aβ(1−42) are in very good agreement with the isotropic growth model. (B) Calculated CCS values for
theoretical models of an Aβ hexamer built using ab intitio docking are shown by the horizontal lines. The blue structure is the structure given by the
docking program. The tan structure represents a reﬁned version of the blue structure where the energy has been minimized by Monte Carlo/
Molecular Dynamics simulation. The green structure is the blue structure without the N-terminal (1−16) part. The red boxes show the
experimentally found CCS values for the Aβ(1−42) hexamer for each charge state. The results show that N-terminal extendedness and/or
orientation could explain the charge dependent changes in CCS.
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is slightly smaller than the most compact charge state observed.
The observed CCS values for the oligomers increase by around
10% for each added charge (Figure 3B). As most charges
should be located in the N-terminal segments, a charge−charge
repulsion driven expansion is expected in these parts of the
molecules, as has been reported for the isolated Aβ(1−16)
segment.44 This reasoning agrees with the observation that the
experimental CCS values lie between the CCS of the N-
terminal free model and the CCS of the model where the N-
terminal parts are largely extended and are protruding outward
from the center (Figure 3B). Reﬁnement of the ab initio
docking model by the Web server GalaxyReﬁneComplex where
the structure has been allowed to relax and reach an energy
minimum does indeed yield a structure with a slightly smaller
CCS of 2310 Å2, which agrees better with the measured values.
This model value is also close to the CCS of the experimentally
highly populated +9 charge state (2236 Å2) (Figure 3B).
As mentioned above this hexamer model is big enough to
easily form a pore-like structure with a hollow channel in the
middle of the oligomer. It also seems likely that the opening
and internal cavity of this modeled β-barrel hexamer structure
is big enough (8.9 Å at the narrowest point) for ions to
transverse the membrane through this channel. In Figure 6A
the internal cavity of the top scored β-barrel structure is shown
together with a divalent calcium ion (green) at the narrowest
point of the channel. Figure 6A also shows that the height of
the oligomeric peptide complex roughly agrees with the bilayer
thickness of a typical lipid membrane.
Other symmetric hexameric structures were also constructed
for comparison, including tilted hexameric barrels, star shaped
hexamers, dimers of trimers, and trimers of dimers. These are
summarized in Figure S16. The experimental CCS range can
then be used to ﬁlter out modeled structures which are
signiﬁcantly diﬀerent from the measured values. The barrel-like
structures (the proper symmetric barrels described above, as
well as a compact trimer of dimers which is also a barrel-like
structure) were the most compact structures as well as the only
structures with CCS values within the experimental measured
CCS range (Figure 6B). No models had CCS values in
agreement with the smallest CCS values determined from IM-
MS. It is well-known that protein structures, particularly
hollow ones, often collapse slightly in the gas phase, forming
more compact folds due to increased electrostatic inter-
actions.38 Gas phase collapse could therefore yield exper-
imental structures which are slightly more compact than the
models obtained from docking. It has recently been reported
that Aβ oligomers undergo a slight shift in secondary structure
toward helical structure in the most hydrophobic segments
upon transfer to the gas phase.54 A hexamer formed from
docking of helical Aβ peptides (pdb: 2lfm55) gives a similar
CCS (2560 Å2) as the β-barrel structures. This illustrates the
limitation of CCS in distinguishing between diﬀerent
secondary structure elements. The CCS value should rather
be seen to inform about the overall oligomer symmetry and
size.
■ CONCLUDING REMARKS
Native mass spectrometry was used to detect the formation of
Aβ(1−42)β-barrel pore forming oligomers (βPFOsAβ(1−42))
and to describe their exact oligomeric states. These oligomeric
structures, which could represent some of the most neurotoxic
Aβ species, are diﬃcult to study using other techniques, as the
Aβ population is very heterogeneous. The βPFOsAβ(1−42) are
furthermore associated with detergent molecules, making the
exact oligomer sizes diﬃcult to determine in solution. As mass
spectrometry is a nonaveraging technique, it is possible to
separately detect all species present in the sample. It is also
possible to strip the peptide−micelle complexes down to pure
peptide oligomers with distinct masses by carefully applying
collisional energy in the mass spectrometer.
In the β-sheet structured size exclusion chromatography
fraction, we could conﬁdently detect oligomer sizes up to
hexamers. The spread in oligomer sizes further illustrates the
heterogeneity of the peptide population also in a somewhat
stabilizing membrane-mimicking environment. Oligomers
larger than tetramers are probably big enough to form pore
structures and therefore warrant special attention. Such
potentially pore-forming oligomers were exclusively observed
for Aβ(1−42), while Aβ(1−40) mostly formed dimers and
trimers. No heptamers or octamers could be detected even at
low collisional energies, which could possibly indicate that the
hexamer is the largest oligomeric state in this particular system.
The importance of the hexamer in the oligomerization pathway
for Aβ(1−42) in solution has previously been demonstrated.6
It has however been envisioned that the hexamers go on to
form the so-called Aβ(1−42) globulomer (60−100 kDa
oligomer found in solution), consisting of two stacked
hexamers with the hydrophobic C-terminal ends of both
hexamers at the center of the structure.6,56 The fact that we do
Figure 6. (A) Illustration of the best scored docked hexamer structure
(symmetric β-barrel) with the width of the internal channel indicated
at the narrowest and widest points. A Ca2+ ion is shown for
comparison (green) inside the channel. The height of the hexamer is
approximately the same as the thickness of the DPPC (PC 16:0)
bilayer shown in gray (carbon atoms)/red (oxygen atoms). (B)
Overview of the calculated CCS values for some of the oligomer
structures obtained from ab initio docking. The experimentally
observed CCS mean with 95% conﬁdence interval is shown by the
red line. Some representative structures of Aβ hexamer models are
shown. Compact barrel-like structures are the models which best
agree with the experimental data.
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not observe such dodecamers could be explained by
stabilization (solvation) of the C-termini by hydrophobic
detergent hydrocarbon tails in our system. Such solvation
would remove the entropic drive for dimerization of hexamers
present in an aqueous solution. This could be an artifact of the
micelle model, but similar stabilizing eﬀects would likely be
present also in a lipid bilayer.
We furthermore show that the smaller oligomers assemble
into larger oligomers upon incubation and that addition of PC
lipids to the micelles stabilizes larger oligomers. The hexamer
was the largest observed oligomers under all tested conditions.
The decrease of ﬁbrillation rate in combination with an
increase in oligomer population indicates the potentially
important role of membranes in Aβ mediated neurotoxicity.
βPFOs could represent an alternative population state for the
Aβ-peptide which is highly neurotoxic and possibly not on-
pathway for amyloid formation. The observed diﬀerence
between βPFO-formation for Aβ(1−42) and Aβ(1−40)
furthermore gives a connection between intrinsic peptide
toxicity and their corresponding ability to form pore-like
structures in membranes.
The experimentally obtained collisional cross section values
for the βPFOs are in good agreement both with isotropic
growth and with a theoretical β-barrel model built using ab
initio docking. Alternative oligomer symmetries are all
signiﬁcantly larger than the cross sections obtained exper-
imentally. Our results therefore prove that oligomeric Aβ
structures are formed and enriched under conditions that have
been shown to induce membrane leakage,22 supporting the
idea of neurotoxic membrane-bound Aβ pores. The hexameric
βPFOsAβ(1−42) described here has many features in common
with the crystal structure of a hexamer formed by a segment of
the amyloid-forming protein of αB crystalin (cylindrin).57 It
was, in the same study, bioinformatically predicted that the C-
terminal part of the Aβ-peptide should also be able to form
such a cylindrin-like hexamer structure. Theoretical MD
models have additionally been presented of hexameric
Aβ(1−42) pores in a PC lipid bilayer.58 Such pores, which
our results now give experimental proof for, could be a highly
relevant part of the pathological mechanism in AD, which of
course in a physiological context could be even more complex.
The methodology presented here could be further applied to
study how diﬀerent speciﬁc lipids could stabilize or destabilize
certain oligomeric forms of the βPFOs, as has been shown
recently for other membrane proteins.59 It is possible that
certain conditions could decrease the heterogeneity and
increase the relative concentration of pore-forming (tetramers
and larger) oligomers. Speciﬁcally, it is known that anionic
lipids, gangliosides, and cholesterol could inﬂuence the Aβ−
membrane interaction.60−63 Aβ sequence variations or
modiﬁcations such as disease related mutants or oxidation
induced covalent cross-linking could also be factors that cause
increased stability of βPFOs and increased neurotoxicity.
βPFOs are interesting potential key players in neurodegenera-
tion and could therefore be interesting as potential targets for
future AD therapies. More generally the approach presented
here could also be applied to other similar targets, as it is
hypothesized by some that many amyloidogenic peptides and
proteins oligomerize and disturb membranes in similar ways.64
Pore formation is also a debated topic within the ﬁelds of cell-
penetrating and antimicrobial peptides.65,66 Our results show
that native ion mobility mass spectrometry is very useful and
an important tool for studies of peptide oligomerization also in
the membrane environment.
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